COVID-19 & CancerTrials & Tribulations Navigating a pandemic in the nonprofit space: Lessons learned from COVID-19 responses October 23, 2020Vol.46 No.40By Patricia J. Goldsmith
COVID-19 & CancerTrials & Tribulations COVID and lung cancer: How experts in cancer and virology joined forces in a challenging time October 16, 2020Vol.46 No.39By Fred R. Hirsch
FreeTrials & Tribulations Overcoming systemic barriers to improve cancer clinical trials October 09, 2020Vol.46 No.38By C. K. Wang
FreeTrials & Tribulations The cancer detection rate—a public health approach to early detection October 02, 2020Vol.46 No.37By Joshua J. Ofman and Azra Raza
COVID-19 & CancerFreeTrials & Tribulations Cancer care in the COVID-19 world: Adjusting to a new reality July 31, 2020Vol.46 No.31By Marcus Neubauer
Trials & Tribulations Assessing the impact of the CMS price transparency rule on patients with prostate cancer July 24, 2020Vol.46 No.30By Ankit Agarwal and Trevor J. Royce
COVID-19 & CancerFreeTrials & Tribulations (Social + geographic) distance = Ongoing challenges in disparities for rural cancer patients July 02, 2020Vol.46 No.27By Jennifer Dill, Marsha Kutter and Peggy Wisher
FreeTrials & Tribulations Mobile pharmacies—driving down rural cancer care disparities June 19, 2020Vol.46 No.25By Justin Floyd, James L. Wade III and Allison Braden
COVID-19 & CancerFreeTrials & Tribulations As screening declines amid COVID-19, at-home stool DNA test for CRC gets high adherence in Medicare population June 12, 2020Vol.46 No.24By Paul J. Limburg
COVID-19 & CancerFreeTrials & Tribulations COVID-19 and cancer: Ethical dilemmas in immune checkpoint blockade April 03, 2020Vol.46 No.14By Allison Betof Warner
